Retatrutide, also catalogued under the research code LY3437943, is a single synthetic peptide studied for its activity at three receptors: GIP, GLP-1 and glucagon. Orion Peptides supplies retatrutide as a lyophilized powder for laboratory and analytical research only. It is not for human or veterinary use.
For researchers, the hard part isn’t finding a listing. It’s knowing whether the vial contains what the label says. This guide covers what a credible retatrutide certificate of analysis (COA) shows, and how to check one.
What makes retatrutide harder to verify than shorter peptides
Retatrutide is a long, modified peptide. Longer sequences give synthesis more chances to produce near-identical side compounds: truncated chains, deletions or incomplete modifications. These can sit close to the main peak on a chromatogram. A single “99%” figure tells you little unless the method behind it is shown.
For background on the compound itself, see What Is LY3437943? and GIP, GLP-1 and Glucagon Receptors Explained.
The five checks a retatrutide COA should pass
- HPLC purity with the chromatogram attached. You want the trace, not just a percentage. Look for a dominant main peak and labelled impurity peaks.
- Identity test. Mass spectrometry (LC-MS) is the strongest method, showing an observed mass that matches retatrutide’s expected molecular weight. HPLC against a reference standard is also common. Purity without identity only proves the vial is pure something.
- Net peptide content. This is the measured milligrams in the vial. An independent September 2026 review of 664 vendor certificates found a median reported purity of 99.74%. Yet only 49% of vials were within ±5% of their labelled mass (PepIndex).
- A named testing laboratory. The lab’s name should be on the report, and the report should be retrievable or confirmable with the lab.
- A batch number and test dates. The certificate should tie to a specific production batch, not just a compound name.
Our full walkthrough is in How to Read a Peptide COA and our 7-point COA credibility check.
How Orion Peptides handles retatrutide quality
Every Orion Peptides batch is tested by a third-party laboratory, Hyte Research Division. Current certificates are available on our COA Verification page. Orion Peptides retatrutide is available in several research strengths:
Orders ship from within the USA, and Orion Peptides also ships to Canada. For handling once a vial arrives, see the Retatrutide Storage Guide.
Red flags when sourcing retatrutide for research
- A purity figure with no chromatogram or no identity test
- A COA with no laboratory name, or one that can’t be confirmed
- Compound pages that describe effects in people, outcomes or how to use the compound. Legitimate research suppliers don’t.
- Prices far below the market for the same strength, with no testing shown
Shop: Retatrutide research strengths
FAQ
Is retatrutide for human use? No. Orion Peptides retatrutide is sold strictly for laboratory and analytical research. It is not a drug, supplement or cosmetic.
What does LY3437943 mean? It’s the development code under which retatrutide appears in the scientific literature.
Where can I see the COA for Orion Peptides retatrutide? On our COA Verification page, or by contacting support with your order number.
Relevant resources
- PepIndex — September 2026 analysis of 664 peptide certificates
- ISO/IEC 17025:2017 — competence of testing laboratories
- FDA — Synthetic peptide guidance (impurity characterization), May 2021
All Orion Peptides compounds are for research use only. Not for human or veterinary use.
